BRONCHOPULMONARY LESIONS AND QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS
https://doi.org/10.17650/1818-8338-2011-2-52-56
Abstract
Aim – assessment of quality of life (QoL) in patients with rheumatoid arthritis (RA) with the presence and severity of bronchopulmonary lesions.
Materials and methods. The study included 104 patients with RA and 100 patients not suffering from RA and verified chronic respiratory diseases. The analysis of the QOL of patients using questionnaires EQ-5D (EuroQoL Group, 1990) and SGRQ (St. George's Hospital questionnaire to assess respiratory function), performed spirometry, bodyplethysmography , pulse oximetry, the definition of lung diffusion
capacity, multispiral computed tomography of the lungs.
Results. Performance of all scales and the resulting indices of questionnaires EQ-5D and SGRQ showed a significant decrease in QoL of
RA patients compared with those in control group and the general population. A correlation index of EQ-5D with vital capacity (r = 0.47;
p < 0.001) and diffusion capacity (r = 0.67; p < 0.01) of the lungs is revealed. The main reason for the reduction of indices of the questionnaire SGRQ in patients with RA was the presence of shortness of breath. The multi-factorial origin of dyspnea in patients with RA with the
essential role of bronchopulmonary lesions was established.
Conclusion. Bronchopulmonary lesions in the underlying disease have an adverse impact on the QOL of patients with RA. Promising directions for improving the QOL of RA patients with bronchial lesions can be considered for activities for the conservation of respiratory lung function, exercise control RA activity, elimination of anemia correction of psycho-emotional disturbances of anxiety-depressive character.
About the Authors
M. V. SheyanovRussian Federation
Faculty Therapy Department №1, Medical Faculty
I. S. Schedrina
Russian Federation
Vinogradov Faculty Therapy Clinic
V. A. Sulimov
Russian Federation
Faculty Therapy Department №1, Medical Faculty
References
1. Амирджанова В.Н. Ревматоидный артрит с позиций оценки качества жизни больных. Терапевтический архив 2007;(5):9–15.
2. Brooks P., Boers M., Simon L., et al. Outcome measures in rheumatoid arthritis –the OMERACT process. Expert Rev Clin Immunol 2007;3:271–5.
3. Linde L., Sorensen J., Ostergaard M., et al. Health-related quality of life: validity, reliability, and responsiveness of SF-36, EQ-15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol 2008;35:1528–37.
4. Gabriel S.E., Crowson C., Kremers H., et al. Survival in rheumatoid arthritis: a populationbased
5. analysis of trends over 40 years. Arthritis Rheum 2003;48:54–8.
6. Swinson D.R., Symmons D., Suresh U., et al. Decreased survival in patients with co-existent
7. rheumatoid arthritis and bronchiectasis. Br J Rheumatol 1997;36:689–91.
8. Turesson C., Matteson E. Management of extra-articular disease manifestations in rheumatoid arthritis. Curr Opin Rheumatol 2004;16:206–11.
9. Crestani B. The respiratory system in connective tissue disorders. Allergy 2005;60:715–34.
10. Brown K. Rheumatoid lung disease. Proc Am Thorac Soc 2007;4:443–8.
11. Шеянов М.В., Терновой С.К., Фоминых Е.В. и др. Поражения легких и нижних дыхательных путей у больных ревматоидным артритом. Клиническая медицина 2010;(2):46–50.
12. Arnett F., Edworthy S., Bloch D., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
13. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy
14. ;16:199–208.
15. Jones P.W., Quirk F.H., Baveystock C.M. The St George's Respiratory Questionnaire. Respir
16. Med 1991;85(Suppl B):25–31.
17. Beretta L., Santaniello A., Lemos A., et al. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the healthrelated quality of life in patients with interstitial lung disease secondary to systemic sclerosis. Rheumatology 2007;46:296–301.
18. Ferrer M., Villasante C., Alonso J., et al. Interpretation of quality of life scores from the St George's Respiratory Questionnaire. Eur Respir J 2002;19:405–13.
19. MVH Group. The measurement and valuation of health. Final report on the modelling of valuation tariffs. York Centre for Health Economics, 1995.
20. Domindo-Salvany A., Lamarca R., Ferrer M., et al. Health-related quality of life and mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:680–5.
21. Gallefoss F., Bakke P.S., Kjaersgaard P. Quality of life assessment after patient education
22. in a randomized controlled study on asthma and chronic obstructive pulmonary disease. Am J
23. Respir Crit Care Med 1999;159:812–7.
24. Руководство по диагностике, лечению и профилактике бронхиальной астмы и одышки. Российское респираторное общество. Под ред. А.Г. Чучалина. М., 2005.
25. Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis. Lancet 1965;1(7389):775–9.
26. Авдеев С.Н., Чучалин А.Г. Одышка: механизмы развития, оценка и лечение: Пособие для врачей. М., 2002.
27. Dyspnea. Mechanisms, assessment, and management: A Consensus Statement. American Thoracic Society. Am J Respir Crit Care Med 1999;159:321–40.
Review
For citations:
Sheyanov M.V., Schedrina I.S., Sulimov V.A. BRONCHOPULMONARY LESIONS AND QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS. The Clinician. 2011;5(2):52-56. (In Russ.) https://doi.org/10.17650/1818-8338-2011-2-52-56